BDTX · Black Diamond Therapeutics, Inc.

$1.66 -0.10 (-5.68%) At close · Jul 29

Market Cap

$95.12M

57.30M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Mark A. Velleca	CEO	$667,400	—	$189,000	$1,006,030	$348,717	$23,772	$2,234,919
Sergey Yurasov	Chief Medical Officer	$525,600	—	$189,000	$402,348	$212,342	$22,806	$1,352,097
Brent Hatzis-Schoch	COO	$511,000	—	$189,000	$352,029	$206,444	$23,772	$1,282,245

Fiscal 2024

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Mark A. Velleca	CEO	$644,800	—	—	$1,882,269	$319,176	$8,866	$2,855,111
Sergey Yurasov	Chief Medical Officer	$507,800	—	—	$788,851	$197,026	$21,143	$1,514,820
Brent Hatzis-Schoch	COO	$493,700	—	—	$701,381	$191,556	$18,479	$1,405,116

Fiscal 2023

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Mark A. Velleca	CEO	$180,833	—	—	$2,591,404	$113,667	$63,950	$2,949,854
David M. Epstein	CEO	$412,300	—	—	$1,049,520	—	$557,386	$2,019,206
Fang Ni	CFO	$450,865	—	—	$823,542	$189,361	$25,758	$1,489,526
Sergey Yurasov	Chief Medical Officer	$488,250	—	—	$514,760	$205,065	$25,609	$1,233,684

Fiscal 2022

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
David M. Epstein	CEO	$554,350	—	—	$759,775	$310,436	$20,296	$1,644,857
Brent Hatzis-Schoch	COO	$452,100	—	—	$227,932	$207,743	$23,452	$911,227
Fang Ni	CFO	$411,740	—	—	$253,426	$196,977	$47,616	$909,759

Fiscal 2021

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
David M. Epstein	CEO	$538,201	—	—	$4,235,494	$228,735	$87,795	$5,090,225
Brent Hatzis-Schoch	COO	$438,901	—	—	$1,411,832	$149,226	$22,350	$2,022,309
Fang Ni	CFO	$388,101	$25,000	—	$1,035,343	$131,955	$94,171	$1,674,570

Fiscal 2020

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
David M. Epstein	CEO	$507,825	—	—	$3,030,428	$270,400	$59,563	$3,868,216
Rachel Humphrey	Chief Medical Officer	$144,621	$25,000	$281,400	$2,469,000	$49,000	$10,267	$2,979,288
Brent Hatzis-Schoch	COO	$418,333	$50,000	—	$856,811	$184,800	$17,100	$1,527,044

Fiscal 2019

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
David M. Epstein	CEO	$428,904	—	—	$2,728,815	$171,562	$16,800	$3,346,081

Key facts CIK 1701541 CUSIP 09203E105 13F (30d) 14 filings 14 filers Visit website Investor relations